Efficacy of Azvudine Therapy in Patients with Severe and Non-Severe COVID‐19: A Propensity Score-Matched Analysis
Azvudine treatment shortens hospital stay length and increases the rate of lymphocyte count improvement in patients with non-severe COVID-19, suggesting that azvudine may be a treatment option for these patients.
Authors
- Bin Yang (ORCID: https://orcid.org/0000-0001-7948-3823)
- S H Zhang
- Lin Liu (ORCID: https://orcid.org/0000-0002-1947-0809)
- Songsong Tan (ORCID: https://orcid.org/0009-0000-2259-9059)
- Guohang Yuan
- Yaoyao Wu (ORCID: https://orcid.org/0000-0003-0766-1541)
- Fengjiao Chen (ORCID: https://orcid.org/0000-0002-0995-4607)
Institutions
- Guizhou Provincial People's Hospital (CN)
Publication Details
- Journal
- Infection and Drug Resistance
- Published
- 2024-10-01
- DOI
- https://doi.org/10.2147/idr.s481591
- Citations
- 1
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.39